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Obesity paradox is a term for a medical hypo-
thesis which holds that obesity can counterintuitively 
be protective and associated with greater survival 
in heart failure (HF) patients [1, 2]. Although obe-
sity is a risk factor for the development of HF and 
increases the prevalence of classical cardiovascular 
risk factors (hypertension, insulin resistance, dia-
betes mellitus and hyperlipidemia), obese patients 
with HF seem to enjoy a more favorable clinical 
prognosis [3, 4]. Even more, basic scientific and 
animal studies identified detrimental effects of adi-
posity and insulin resistance on the endothelium, 
cardiac function and remodeling [5, 6]. Thus, it is 
surprising that obese and overweight HF patients 
seem to have better prognosis than lean patients.
The Atherosclerosis Risk in Communities 
(ARIC) study [7] illustrates this phenomenon 
well. During a decade of retrospective longitu-
dinal data collection, the authors show that even 
pre-morbid obesity is associated with improved 
outcome in HF patients [8]. In ARIC, the authors 
follow-up 1,487 patients with incident HF who 
had body mass index (BMI) measured at least 
6 months prior to diagnosis. The mean interval 
between BMI assessment and HF diagnosis was 
4 years, ensuring that the BMI measurement 
was not confounded by HF related factors. After 
adjustment for clinical risk factors, pre-morbid 
overweight and obesity were associated with 23% 
and 25% reductions, respectively, in mortality risk 
during 10-year follow-up.
This improved clinical outcome in obese 
patients with HF is an epidemiological confound-
ing observation, named “reverse epidemiology”, 
a confusing term itself [9]. The “obesity paradox” 
was coined initially in dialysis patients less than 
12 years ago. This concept was discussed only 
briefly in textbooks [10], and is not mentioned in 
the European Society of Cardiology (2012) and 
American Heart Association/American College of 
Cardiology (2013) Heart Failure Guidelines [11, 12]. 
As mentioned above, the “obesity paradox” is 
an observational finding, which has not adhered to 
scientific validation methods, i.e. active modifica-
tion of the possible casualties will lead to modi-
fication of the observation. In order help clarify 
the paradox, Zafrir et al. [13] evaluated this issue 
applying body surface area (BSA) instead BMI be-
cause BSA is a more precise metabolic mass index 
than the BMI and is not influenced by abnormal 
adipose mass. The author’s findings indicate that 
BSA is a stronger predictor of mortality than other 
measures of body habitus, irrespective of height 
correction. The greater the overall bulk of the body, 
the better the survival. BSA provides prognostic 
information similar to BMI in systolic HF. This is 
concordant with previous studies such as those 
by Futter et al. [14] and Frankenstein et al. [15].
In order to investigate different confound-
ers, Zafrir et al. [13] performed adjusted analysis 
from multivariate variables. They concluded that 
young age was the main bias factor which makes 
sense being that younger patients have a higher 
chance of living longer. This finding helps prove 
that the “obesity paradox” is more of a statistical 
manipulation than a real occurrence. The U-shaped 
relationship between body mass and outcome re-
ported from epidemiological studies becomes much 
flatter with increasing age (Fig. 1) and perhaps with 
chronic illness it is moved to the right [16].
Why do we need to understand this paradox? 
Does this observation have direct clinical implica-
tions? At this point, it is difficult to determine. 
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Additional studies must be conducted in order 
to understand this paradox across longer period 
of time and should focus on other related factors 
such as metabolic and physiological data, fat dis-
tribution, degree of insulin resistance in various 
HF stages and functional class. If we adopt this 
paradox as a scientific fact, the weight reduction 
will be contraindicated in HF patients, which can 
be a detrimental effect! There is little evidence 
regarding the impact of weight loss in obese HF and 
whether or not this is beneficial. There have been 
small studies regarding the cardiovascular effects 
of both dietary weight loss and bariatric surgery, 
but few in HF. This is an important and increasingly 
relevant clinical question which must be addressed. 
To understand physiological consequences of 
obesity in HF, further work is warranted in basic 
and clinical investigation. Human studies need to 
include more detailed metabolic and physiological 
data, fat distribution, degree of insulin resistance 
in various HF stages and functional class.
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